Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis
NCT02687919 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2019-08-12
Summary
This is a research study. The investigators are inviting participants to participate in this research study between the ages of 18-45, who have stable Relapsing-Remitting Multiple Sclerosis (RRMS), are able to walk 25 ft with/without an assistive device, and have none of the following: liver disease, kidney disease, diabetes, active heart disease, heart block or arrhythmias, bleeding disorders, concurrent diuretic use, anti-coagulation or anti-platelet use, psychosis or other psychiatric disorder likely to impact ability to comply with study procedures, any change in prescription medication for a mental health problem such as depression or anxiety in the last three months.
The purpose of this research study is to determine whether or not a modified Paleolithic diet results in any change in health in persons with RRMS compared to usual care. The investigators define usual care as the typical or usual physician recommendations for the treatment of RRMS.
The Paleolithic diet (or Paleo diet), also referred to as the caveman diet, Stone Age diet, and hunter-gatherer diet, is a modern nutritional plan based on the presumed ancient diet of wild plants and animals of ancestral humans during the Paleolithic era (a period of about 2.5 million years duration that ended around 10,000 years ago with the development of agriculture). The diet consists mainly of fish, grass-fed pasture raised meats, vegetables, fruit, fungi, roots, and nuts, and excludes grains, legumes, dairy products, salt, refined sugar, and processed oils.
To the investigators' knowledge, most neurologists prescribe medications that may reduce or prevent future disability, but few prescribe dietary modifications unless needed for other concomitant disease.
Conditions
- Multiple Sclerosis, Relapsing-remitting
Interventions
- OTHER
-
Modified Paleo diet
Nine cups of vegetables and some fruits, meat protein including organ meat, and complete abstinence from products containing gluten (wheat, barley, rye, etc.), dairy, potatoes, and legumes (beans, lentils, peanuts, soy, etc.)
Sponsors & Collaborators
-
Amanda Irish
lead OTHER
Principal Investigators
-
Amanda K Irish · University of Iowa
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-10-31
Countries
- United States
Study Locations
More Related Trials
-
A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668
NCT02313285 ·Status: COMPLETED
-
Genes and Environment in Multiple Sclerosis
NCT01353547 ·Status: RECRUITING
-
Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS
NCT03718247 ·Status: COMPLETED
-
Functional Outcomes From Diets in Multiple Sclerosis
NCT05327322 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study Evaluating CCI-779 in Relapsing Multiple Sclerosis
NCT00228397 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
NCT02647502 ·Status: COMPLETED ·Phase: NA
-
Nutritional Approaches in Multiple Sclerosis
NCT03508414 ·Status: UNKNOWN ·Phase: NA
-
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
NCT04009005 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
NCT02133664 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
NCT00919217 ·Status: TERMINATED
-
Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis
NCT03025269 ·Status: COMPLETED
-
Vitamine D in Multiple Sclerosis
NCT01768039 ·Status: UNKNOWN ·Phase: PHASE3
-
Time Restricted Eating Outcomes in Multiple Sclerosis
NCT04389970 ·Status: COMPLETED ·Phase: NA
-
TMP001 in Relapsing-remitting Multiple Sclerosis
NCT02686788 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis
NCT01538355 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-
NCT04843813 ·Status: UNKNOWN ·Phase: NA
-
Patient Research Cohort: Rapidly Evolving Multiple Sclerosis
NCT01044576 ·Status: COMPLETED
-
POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler
NCT01051817 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis
NCT02442570 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis
NCT07037823 ·Status: NOT_YET_RECRUITING
-
Intellectual Enrichment to Build Cognitive Reserve in MS
NCT01978574 ·Status: COMPLETED ·Phase: NA
-
Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
NCT00203047 ·Status: TERMINATED ·Phase: PHASE4
-
IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis
NCT06677710 ·Status: SUSPENDED ·Phase: PHASE1
-
Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients
NCT03610139 ·Status: UNKNOWN ·Phase: NA